Crestwood Advisors Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.47M | Sell |
10,043
-232
| -2% | -$103K | 0.08% | 141 |
|
|
2025
Q1 | $4.98M | Buy |
10,275
+4,476
| +77% | +$2.17M | 0.09% | 127 |
|
|
2024
Q4 | $2.34M | Buy |
5,799
+121
| +2% | +$48.7K | 0.04% | 175 |
|
|
2024
Q3 | $2.64M | Buy |
5,678
+46
| +0.8% | +$21.4K | 0.05% | 164 |
|
|
2024
Q2 | $2.64M | Buy |
5,632
+99
| +2% | +$46.4K | 0.05% | 151 |
|
|
2024
Q1 | $2.31M | Buy |
5,533
+436
| +9% | +$182K | 0.05% | 159 |
|
|
2023
Q4 | $2.07M | Buy |
5,097
+90
| +2% | +$36.6K | 0.05% | 159 |
|
|
2023
Q3 | $1.74M | Buy |
+5,007
| New | +$1.74M | 0.05% | 163 |
|
|
2021
Q1 | – | Sell |
-1,230
| Closed | -$291K | – | 278 |
|
|
2020
Q4 | $291K | Sell |
1,230
-178
| -13% | -$42.1K | 0.01% | 215 |
|
|
2020
Q3 | $383K | Buy |
1,408
+3
| +0.2% | +$816 | 0.01% | 182 |
|
|
2020
Q2 | $408K | Sell |
1,405
-7
| -0.5% | -$2.03K | 0.02% | 176 |
|
|
2020
Q1 | $336K | Buy |
1,412
+7
| +0.5% | +$1.67K | 0.02% | 173 |
|
|
2019
Q4 | $308K | Sell |
1,405
-50
| -3% | -$11K | 0.01% | 209 |
|
|
2019
Q3 | $247K | Sell |
1,455
-1
| -0.1% | -$170 | 0.01% | 220 |
|
|
2019
Q2 | $267K | Buy |
+1,456
| New | +$267K | 0.01% | 203 |
|